Clinical trial
Motivating HIV+ Women: Risk Reduction and ART Adherence
NCT00253045 · Emory University, Other · Completed
Key facts
| NCT number | NCT00253045 |
|---|---|
| Title | Motivating HIV+ Women: Risk Reduction and ART Adherence |
| Official title | Motivating HIV+ Women: Risk Reduction and ART Adherence |
| Acronym | KHARMA |
| Lead sponsor | Emory University, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | HIV, AIDS |
| Intervention type | Behavioral |
| Interventions | Motivational groups |
| Enrollment | 207 |
| Start date | Aug 1, 2004 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Nov 15, 2005 |
| Last update posted | Sep 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: